J.-P. Droz

Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer.

S. Culine, C. Théodore, J. Droz, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy.

S. Culine, J. Droz, J. Kattan, 1995, Gynecologic oncology.

Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.

S. Culine, C. Théodore, J. Droz, 2001, European journal of cancer.

Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything.

S. Culine, R. Motzer, J. Droz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of ondansetron plus dexamethasone in fractionated chemotherapy.

S. Fosså, D. Dearnaley, R. Henriksson, 1993, Oncology.

Pure malignant immature teratoma of the ovary: the role of chemotherapy and second-look surgery

S. Culine, J. Droz, J. Kattan, 1995, International Journal of Gynecologic Cancer.